Eiger BioPharmaceuticals, Inc. Purchase Agreements
9 Contracts & Agreements
- Asset Purchase Agreement, dated June 21, 2024 (Filed With SEC on June 21, 2024)
- Asset Purchase Agreement, dated June 13, 2024 (Filed With SEC on June 14, 2024)
- Asset Purchase Agreement, dated March 31, 2024, by and between Sentynl Therapeutics, Inc. and Eiger BioPharmaceuticals, Inc (Filed With SEC on April 1, 2024)
- Asset Purchase Agreement, by and between Eiger BioPharmaceuticals, Inc. and AbbVie Inc., dated as of November 20, 2020 (Filed With SEC on March 9, 2021)
- Asset Purchase Agreement, dated September 25, 2015, by and between Eiger BioPharmaceuticals, Inc. and Tracey McLaughlin and Colleen Craig (Filed With SEC on March 9, 2021)
- Purchase Agreement, dated as of May 24, 2018, by and between Eiger BioPharmaceuticals, Inc. and Piper Jaffray & Co (Filed With SEC on May 25, 2018)
- ASSET PURCHASE AGREEMENT among: EIGERBIOPHARMACEUTICALS, INC. a Delaware corporation; and EICCOSE, LLC, a Delaware limited liability company Dated as ofOctober 29, 2015 ASSET... (Filed With SEC on December 14, 2015)
- ASSET PURCHASE AGREEMENT among: EIGER BIOPHARMACEUTICALS,INC., a Delaware corporation; and TRACEY MCLAUGHLIN ANDCOLLEEN CRAIG Dated as of September 25, 2015 ASSET PURCHASE... (Filed With SEC on December 14, 2015)
- ASSET PURCHASE AGREEMENT (Filed With SEC on December 14, 2015)
